CN Patent

CN115304596A — Valbenazine盐及其多晶形物

Assigned to Neurocrine Biosciences Inc · Expires 2022-11-08 · 4y expired

What this patent protects

本文提供了无定形和结晶形式的(S)‑2‑氨基‑3‑甲基‑丁酸(2R,3R,11bR)‑3‑异丁基‑9,10‑二甲氧基‑1,3,4,6,7,11b‑六氢‑2H‑吡啶并[2,l‑a]异喹啉‑2‑基酯的盐，和制备方法及其药物组合物。还提供了它们用于治疗、预防或改善神经性病症和疾病(包括运动机能亢进性运动障碍或疾病)的一种或多种症状的方法。

USPTO Abstract

本文提供了无定形和结晶形式的(S)‑2‑氨基‑3‑甲基‑丁酸(2R,3R,11bR)‑3‑异丁基‑9,10‑二甲氧基‑1,3,4,6,7,11b‑六氢‑2H‑吡啶并[2,l‑a]异喹啉‑2‑基酯的盐，和制备方法及其药物组合物。还提供了它们用于治疗、预防或改善神经性病症和疾病(包括运动机能亢进性运动障碍或疾病)的一种或多种症状的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN115304596A
Jurisdiction
CN
Classification
—
Expires
2022-11-08
Drug substance claim
No
Drug product claim
No
Assignee
Neurocrine Biosciences Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.